Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Clinical manifestations, diagnosis, and treatment of sarcoidosis
P Ungprasert, JH Ryu, EL Matteson - Mayo Clinic Proceedings: Innovations …, 2019 - Elsevier
The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …
[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative
Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …
based recommendations for the treatment of noninfectious uveitis in the era of biologics …
Methotrexate for ocular inflammatory diseases
S Gangaputra, CW Newcomb, TL Liesegang… - Ophthalmology, 2009 - Elsevier
PURPOSE: To evaluate the outcome of treatment with methotrexate for noninfectious ocular
inflammation. DESIGN: Retrospective cohort study. PARTICIPANTS: Patients with …
inflammation. DESIGN: Retrospective cohort study. PARTICIPANTS: Patients with …
Visual loss in uveitis of childhood
J De Boer, N Wulffraat, A Rothova - British Journal of Ophthalmology, 2003 - bjo.bmj.com
Aims: To investigate the manifestations and severity of uveitis in children and to identify the
risk and specific causes of blindness in this population. Methods: Retrospective study of data …
risk and specific causes of blindness in this population. Methods: Retrospective study of data …
Uveitis: a potentially blinding disease
OM Durrani, CA Meads, PI Murray - Ophthalmologica, 2004 - karger.com
Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune,
conditions predominantly occurring in the working age group. Although the aetiology is …
conditions predominantly occurring in the working age group. Although the aetiology is …
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
Background Conventional pharmacological therapies for the treatment of juvenile idiopathic
arthritis (JIA) consist of non-biological, disease-modifying antirheumatic drugs, among which …
arthritis (JIA) consist of non-biological, disease-modifying antirheumatic drugs, among which …
A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
JA Smith, DJS Thompson, SM Whitcup… - Arthritis Care & …, 2005 - Wiley Online Library
Objective To investigate the safety and efficacy of etanercept in the treatment of uveitis
associated with juvenile idiopathic arthritis (JIA). Methods Children who met the American …
associated with juvenile idiopathic arthritis (JIA). Methods Children who met the American …
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation
PURPOSE: To compare the relative effectiveness and side effect profiles of antimetabolite
drugs in the treatment of noninfectious ocular inflammation. DESIGN: Retrospective cohort …
drugs in the treatment of noninfectious ocular inflammation. DESIGN: Retrospective cohort …
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis
A Heiligenhaus, H Michels, C Schumacher… - Rheumatology …, 2012 - Springer
Uveitis in juvenile idiopathic arthritis (JIA) is frequently associated with the development of
complications and visual loss. Topical corticosteroids are the first-choice therapy, and …
complications and visual loss. Topical corticosteroids are the first-choice therapy, and …
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial
RP Baughman, EE Lower, DA Bradley, LA Raymond… - Chest, 2005 - Elsevier
Purpose Study a tumor necrosis factor receptor antagonist (etanercept) in the treatment of
chronic ocular sarcoidosis Subjects and methods Eighteen patients with ocular sarcoidosis …
chronic ocular sarcoidosis Subjects and methods Eighteen patients with ocular sarcoidosis …